Latest findings, published in Physical Therapy Journal, show high effectiveness, efficiency and patient satisfaction with telerehabilitation and could lead to better reimbursement
PITTSBURGH, June 7, 2022 /PRNewswire/ — A reported 82 percent of physical therapy patients with low back pain who received telerehabilitation (TR) during the COVID-19 pandemic were very satisfied with their treatment results, according to a new study from Focus on Therapeutic Outcomes (FOTO), a Net Health company. The research from FOTO, a provider of the industry-leading outcomes management system for physical therapy, is the most comprehensive to date on TR and also showed that outcomes were equally effective and more efficient compared to those from traditional in-person office visits.
Published in the most recent edition of the American Physical Therapy Association’s Physical Therapy and Rehabilitation Journal, the study, “Is Telerehabilitation a Viable Option for Patients with Low Back Pain? Associations Between Telerehabilitation and Outcomes During the COVID-19 Pandemic,” explores effectiveness (functional status), efficiency (number of visits), and patient satisfaction outcomes. Using the FOTO database, the study examined 91,117 total episodes of care, 5,013 of which included or were exclusively telehealth visits. The research looked at data from 1,398 clinics in 46 states for patients who used at least some telerehabilitation between Q2 of 2020 and Q1 of 2021.1
The key findings highlight the effectiveness, efficiency and patient satisfaction of telerehabilitation and come at a time when patients, employers, providers, and payers are seeking alternative care models toward effective and efficient ways to manage and treat low back pain. The study showed:
The study was conducted during the height of the COVID-19 pandemic when an increased number of patients, experiencing mandatory lockdowns and reduced physical activity levels, sought care for chronic low back pain3.
“We need to encourage more providers as well as payers to embrace and reimburse telerehabilitation, especially for patients who have difficulty accessing care due to disability or socioeconomic factors,” said Mark W. Werneke, PT, MS, Dip. MDT, lead author of the study article and Clinical Research Scientist at Net Health FOTO. “Our results support telerehabilitation as a potentially less-expensive and a viable option for rehabilitation care for successfully managing low back pain not only during the current pandemic but also in the post COVID-19 era. We hope this provides the encouragement needed to encourage more wide spread adoption of telerehabilitation.”
For more information on the FOTO telerehabilitation study, contact Deanna Hayes at support@fotoinc.com.
Net Health’s mission is to harness data for human health. Net Health solutions are trusted in over 23,000 facilities across the continuum of care. Our EHR software enables caregivers and their organizations to engage effectively with patients, streamline documentation, staff efficiently, secure maximum appropriate reimbursement and maintain regulatory compliance. Our unique approach to analytics seamlessly presents insights in clinical and operational workflows to improve care and business performance. Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners. www.nethealth.com.
1 Werneke MW, Deutscher D, Hayes D, Grigsby D, Mioduski JE, Resnik LJ, Fapta. Is Telerehabilitation a Viable Option for Patients with Low Back Pain? Associations between Telerehabilitation and Outcomes during the COVID-19 Pandemic. Phys Ther. 2022 Feb 23:pzac020. doi: 10.1093/ptj/pzac020. PMID: 35202466. Physical Therapy, pzac020, https://doi.org/10.1093/ptj/pzac020. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/foto-research-into-physical-therapy-telehealth-highlights-benefits-to-low-back-pain-sufferers-301562330.html
SOURCE Net Health Systems, Inc.
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…